Medical microbiology: laboratory diagnosis of invasive pneumococcal disease.
The laboratory diagnosis of invasive pneumococcal disease (IPD) continues to rely on culture-based methods that have been used for many decades. The most significant recent developments have occurred with antigen detection assays, whereas the role of nucleic acid amplification tests has yet to be fully clarified. Despite developments in laboratory diagnostics, a microbiological diagnosis is still not made in most cases of IPD, particularly for pneumococcal pneumonia. The limitations of existing diagnostic tests impact the ability to obtain accurate IPD burden data and to assess the effectiveness of control measures, such as vaccination, in addition to the ability to diagnose IPD in individual patients. There is an urgent need for improved diagnostic tests for pneumococcal disease--especially tests that are suitable for use in underresourced countries.
Werno
Anja M
AM
Department of Microbiology, Canterbury Health Laboratories, University of Otago, Christchurch, New Zealand.
Murdoch
David R
DR
D000907:Antibodies, Bacterial / Q000097:blood; D000942:Antigens, Bacterial / Q000032:analysis; D001431:Bacteriological Techniques; D001769:Blood / Q000382:microbiology; D002555:Cerebrospinal Fluid / Q000382:microbiology; D003470:Culture Media; D006801:Humans; D008586:Meningitis, Pneumococcal / Q000175:diagnosis / Q000382:microbiology; D021141:Nucleic Acid Amplification Techniques; D011008:Pneumococcal Infections / Q000175:diagnosis* / Q000382:microbiology; D011018:Pneumonia, Pneumococcal / Q000175:diagnosis / Q000382:microbiology; D013183:Sputum / Q000382:microbiology; D013296:Streptococcus pneumoniae / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D003470:Culture Media